Clinical Trial Update: Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of bortezomib and romidepsin in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma; the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Istodax (romidepsin)
• Velcade (bortezomib)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED